100 related articles for article (PubMed ID: 21742415)
1. Lack of detectable diffuse or neuritic plaques and neurofibrillary tangles in the brains of aged hamsters.
Gerhauser I; Wohlsein P; Ernst H; Germann PG; Baumgärtner W
Neurobiol Aging; 2012 Aug; 33(8):1716-9. PubMed ID: 21742415
[TBL] [Abstract][Full Text] [Related]
2. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
Czasch S; Paul S; Baumgärtner W
Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.
Papaioannou N; Tooten PC; van Ederen AM; Bohl JR; Rofina J; Tsangaris T; Gruys E
Amyloid; 2001 Mar; 8(1):11-21. PubMed ID: 11293821
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
6. Age-related lesions in the cerebrum in middle-aged female cynomolgus monkeys.
Kodama R; Yang X; Saski Y; Iwashige S; Tanigawa Y; Yoshikawa T; Nagaoka T; Kamimura Y; Maeda H
Toxicol Pathol; 2010 Feb; 38(2):303-11. PubMed ID: 20124492
[TBL] [Abstract][Full Text] [Related]
7. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.
Price JL; Morris JC
Ann Neurol; 1999 Mar; 45(3):358-68. PubMed ID: 10072051
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria for Alzheimer's disease.
Price JL
Neurobiol Aging; 1997; 18(4 Suppl):S67-70. PubMed ID: 9330988
[TBL] [Abstract][Full Text] [Related]
9. Vacuolation and mineralisation as dominant age-related findings in hamster brains.
Gerhauser I; Wohlsein P; Ernst H; Germann PG; Baumgärtner W
Exp Toxicol Pathol; 2013 May; 65(4):375-81. PubMed ID: 22257562
[TBL] [Abstract][Full Text] [Related]
10. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
13. A 2-process model for neuropathology of Alzheimer's disease.
Mungas D; Tractenberg R; Schneider JA; Crane PK; Bennett DA
Neurobiol Aging; 2014 Feb; 35(2):301-8. PubMed ID: 24080173
[TBL] [Abstract][Full Text] [Related]
14. The neuropathological changes associated with normal brain aging.
Hof PR; Glannakopoulos P; Bouras C
Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
[TBL] [Abstract][Full Text] [Related]
15. Ageing changes in cat brains demonstrated by beta-amyloid and AT8-immunoreactive phosphorylated tau deposits.
Gunn-Moore DA; McVee J; Bradshaw JM; Pearson GR; Head E; Gunn-Moore FJ
J Feline Med Surg; 2006 Aug; 8(4):234-42. PubMed ID: 16603401
[TBL] [Abstract][Full Text] [Related]
16. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
17. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
Kawabata S; Higgins GA; Gordon JW
Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
[TBL] [Abstract][Full Text] [Related]
18. Increased neurofibrillary tangles in the brains of older pedestrians killed in traffic accidents.
Gorrie CA; Rodriguez M; Sachdev P; Duflou J; Waite PM
Dement Geriatr Cogn Disord; 2006; 22(1):20-6. PubMed ID: 16679761
[TBL] [Abstract][Full Text] [Related]
19. [A new method for simultaneous demonstration of senile plaques and Alzheimer's neurofibrillary tangles].
Krutsay M
Zentralbl Pathol; 1994 Nov; 140(4-5):403-5. PubMed ID: 7826989
[TBL] [Abstract][Full Text] [Related]
20. Existence of different types of senile plaques between brain and spinal cord of TgCRND8 mice.
Yuan Q; Su H; Zhang Y; Chau WH; Ng CT; Wu W; Lin ZX
Neurochem Int; 2013 Feb; 62(3):211-20. PubMed ID: 23333593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]